Form 4 Filing for Roger Sawhney

Roger Sawhney, a director at ACTUATE THERAPEUTICS, INC., was granted 15,000 stock options on May 21, 2026. These options have an exercise price of $2.42 and will vest in full on the anniversary of the grant date, May 21, 2036. The transaction, reported on Form 4, indicates Sawhney acquired these options directly. Following this transaction, Sawhney holds 15,000 shares.